Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > LABS is also a "clinical stage" pharma company. "over 20

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Mar 19, 2024 10:43am

129 Views

Post# 35940498

LABS is also a "clinical stage" pharma company. "over 20

strong clinical trials, may in late stage".

How MUCH is that worth? It's worth more than $2.4 billon even if LABS only has a 30% success rate on those 20+ clinical trials. But something must have worked because the NIH is funding them at University of Southern Calfornia, clincial trails known as the Libby study.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023